May 17 (SeeNews) - Romanian drug maker Biofarm [BSE:BIO] said on Tuesday its first quarter net profit plunged 52% on the year to 6.49 million lei ($1.6 million/1.4 million euro) on the back of unfavourable developments in the local pharmaceutical market.